{"id":12638,"date":"2024-10-11T18:16:14","date_gmt":"2024-10-11T16:16:14","guid":{"rendered":"https:\/\/valintermed.com\/?p=12638"},"modified":"2024-10-11T18:16:14","modified_gmt":"2024-10-11T16:16:14","slug":"protsessing-defitsitnye-progeroidnye-laminopatii-pdpl","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/protsessing-defitsitnye-progeroidnye-laminopatii-pdpl\/","title":{"rendered":"Processing-deficient progeroid laminopathies (PDPL)"},"content":{"rendered":"<div class=\"fpm_start\"><\/div>\n<p>Processing-deficient progeroid laminopathies (PDPL) are a rare group of inherited diseases caused by impaired synthesis of lamins, proteins that play a critical role in the structure of the nuclear membrane of cells. These pathologies are characterized by a pronounced predisposition to aging, which manifests itself in clinical symptoms similar to the natural aging of the body. Patients with PDPL often have lesions of the skin, muscle tissue and internal organs, which increases the risk of serious complications and shortens life expectancy. Mutations of genes encoding various lamins play a key role in the pathogenesis of this disease, which leads to disturbances in the nuclear architecture and functional instability of cells, causing their accelerated aging.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-flat ez-toc-counter ez-toc-light-blue ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/protsessing-defitsitnye-progeroidnye-laminopatii-pdpl\/#%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\" >History of the disease and interesting historical facts<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/protsessing-defitsitnye-progeroidnye-laminopatii-pdpl\/#%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\" >Epidemiology<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/protsessing-defitsitnye-progeroidnye-laminopatii-pdpl\/#%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\" >Genetic predisposition to this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/protsessing-defitsitnye-progeroidnye-laminopatii-pdpl\/#%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Risk factors for the development of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/protsessing-defitsitnye-progeroidnye-laminopatii-pdpl\/#%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Diagnosis of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/protsessing-defitsitnye-progeroidnye-laminopatii-pdpl\/#%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\" >Treatment<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/protsessing-defitsitnye-progeroidnye-laminopatii-pdpl\/#%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >List of medications used to treat this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/protsessing-defitsitnye-progeroidnye-laminopatii-pdpl\/#%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Disease monitoring<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/protsessing-defitsitnye-progeroidnye-laminopatii-pdpl\/#%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Age-related features of the disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/protsessing-defitsitnye-progeroidnye-laminopatii-pdpl\/#%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\" >Questions and Answers<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\"><\/span>History of the disease and interesting historical facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Processing-deficient progeroid laminopathies were first described in the scientific literature in the late 20th century, when the first mutations in the genes encoding lamins A and C were identified. Initially, the attention of physicians was attracted by patients demonstrating an unusual aging phenotype, while the mechanisms underlying these diseases remained unclear. In 2003, a study by a group of scientists led by Bloyle clarified the molecular mechanisms underlying the development of PDPL, which led to a more detailed understanding of their genetic basis. In the following years, several cases were reported, allowing us to identify characteristic clinical manifestations and mechanisms of cell damage. These findings became the basis for the development of diagnostic and therapeutic methods, although many aspects of the disease still remain unclear.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\"><\/span>Epidemiology<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The epidemiology of processing-deficient progeroid laminopathies remains a poorly understood area of medicine, but available data indicate a low prevalence. PDPL has an estimated incidence of about 1 in 4 million people. Regional differences can be significant, and the disease is more common in certain ethnic groups, suggesting genetic predispositions. Because of the low prevalence and lack of information on disease records, many cases remain undetected, making it difficult to establish reliable incidence statistics.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\"><\/span>Genetic predisposition to this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The genetic basis of processing-deficient progeroid laminopathies is associated with mutations in the genes encoding lamins A and C (LMNA). The most common mutations include:<\/p>\n<ul>\n<li>Genetic mutations leading to the synthesis of unstable forms of lamins.<\/li>\n<li>Changes in the nucleotide sequence that disrupt the normal structure of the nuclear membrane.<\/li>\n<li>Segmentation duplications and deletions of genes affecting the balance of lamin expression.<\/li>\n<\/ul>\n<p>These mutations lead to disruption of the nuclear membrane integrity, which in turn causes the development of progeria-like symptoms. Inheritance is usually autosomal dominant, which means that the disease can be transmitted from one parent to the offspring with a probability of 50%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Risk factors for the development of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Risk factors for the development of processing-deficient progeroid laminopathies are largely related to genetic predisposition, but there are a number of environmental and secondary factors that can increase the manifestations of the disease:<\/p>\n<ul>\n<li>Heredity: presence of sick people in the family.<\/li>\n<li>Age: Symptoms of the disease are more likely to appear in older people.<\/li>\n<li>Physical stress: Increased physical activity may aggravate the symptoms of the disease.<\/li>\n<li>Chemical factors: Exposure to certain chemicals may potentially worsen the condition of patients.<\/li>\n<li>Infectious diseases: Severe infections can worsen the course of the disease.<\/li>\n<\/ul>\n<p>These factors can not only contribute to the occurrence of primary symptoms, but also worsen the general condition of patients against the background of already existing mutations.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Diagnosis of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The diagnosis of processing-deficient progeroid laminopathies requires a comprehensive approach. The main symptoms include:<\/p>\n<ul>\n<li>Skin changes: skin atrophy, darkening or discoloration.<\/li>\n<li>Muscle weakness and atrophy.<\/li>\n<li>Skeletal abnormalities: joint dysplasia.<\/li>\n<li>Cardiovascular symptoms.<\/li>\n<\/ul>\n<p>Laboratory tests may include:<\/p><script data-noptimize=\"\" data-wpfc-render=\"false\">\nfpm_start( \"true\" );\n<\/script>\n\n<ul>\n<li>Genetic tests to detect mutations in lamin genes.<\/li>\n<li>Tissue biopsy as a source for molecular analysis.<\/li>\n<\/ul>\n<p>Radiological examinations such as MRI or ultrasound are necessary to examine the condition of the heart and other internal organs. Other diagnostics include electromyography and bone scans. It is also important to differentiate from other progeriatic and muscular disorders such as Lammert syndrome and muscular dystrophy.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\"><\/span>Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Treatment of processing deficiency progeroid laminopathies is largely symptomatic and includes <\/p>\n<ul>\n<li>General supportive care: rehabilitation, physical therapy.<\/li>\n<li>Pharmacological treatment: drugs to improve cardiac function, steroids to reduce inflammation.<\/li>\n<li>Surgical treatment: In some cases, surgery may be required if there are skeletal abnormalities.<\/li>\n<li>Other treatments: The use of agents aimed at slowing down cell aging and restoring the nuclear membrane are under research.<\/li>\n<\/ul>\n<p>It is important that therapy is carried out individually, taking into account the clinical manifestations and condition of the specific patient.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>List of medications used to treat this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Drugs used to relieve symptoms and manage processing-deficiency progeroid laminopathies include:<\/p>\n<ul>\n<li>Inositol: to improve membrane integrity.<\/li>\n<li>Coenzyme Q10: to improve energy metabolism in cells.<\/li>\n<li>Cardiac glycosides: to improve cardiac function.<\/li>\n<li>Nonsteroidal anti-inflammatory drugs (NSAIDs): to reduce pain.<\/li>\n<li>Hormones: such as steroids, to manage inflammation.<\/li>\n<\/ul>\n<p>Each specific treatment must be agreed upon with the attending physician.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Disease monitoring<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Monitoring of patients with processing-deficient progeroid laminopathies involves regular examinations to assess disease progression. Key monitoring steps include:<\/p>\n<ul>\n<li>Periodic clinical examination every 3-6 months.<\/li>\n<li>Genetic monitoring to detect new mutations.<\/li>\n<li>Assessment of the functional state of organs and systems using MRI and ultrasound.<\/li>\n<\/ul>\n<p>The prognosis for patients depends on the severity of manifestations and the adequacy of treatment; however, many patients experience serious complications that can significantly increase the risk of premature death.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Age-related features of the disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Processing-deficient progeroid laminopathies have their own age-related characteristics. Children and adolescents have more pronounced symptoms, such as severe muscle atrophy and skeletal deformities. In older patients, the course of the disease slows down significantly, but the risk of cardiovascular diseases increases. In women, melanoma of the skin and other oncological diseases are more often observed compared to men.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\"><\/span>Questions and Answers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>What are the main symptoms of processing deficiency progeroid laminopathies?<\/strong> The main symptoms are skin aging, muscle atrophy and cardiovascular pathologies.<\/li>\n<li><strong>How is the disease diagnosed?<\/strong> Diagnosis includes genetic tests, tissue biopsy and radiological studies.<\/li>\n<li><strong>Are there any specific medications for treatment?<\/strong> There are no specific drugs; therapy is aimed at relieving symptoms.<\/li>\n<li><strong>At what age does the disease begin?<\/strong> Symptoms can appear at any age, but are more common in children and adolescents.<\/li>\n<li><strong>What is the prognosis for patients with this disease?<\/strong> The prognosis varies, but many patients experience significant complications that reduce life expectancy.<\/li>\n<\/ul>\n<div class=\"fpm_end\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Processing-deficiency progeroid laminopathies (PDPL) are a rare group of inherited disorders caused by defects in the synthesis of lamins, proteins that play a critical role<\/p>","protected":false},"author":1,"featured_media":22069,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"class_list":["post-12638","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medlibrary"],"_links":{"self":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/comments?post=12638"}],"version-history":[{"count":1,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12638\/revisions"}],"predecessor-version":[{"id":14441,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12638\/revisions\/14441"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media\/22069"}],"wp:attachment":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media?parent=12638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/categories?post=12638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/tags?post=12638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}